Current Challenges and New Opportunities of Hybrid Nanoparticles for Diagnosis and Treatment of Cancer
Abstract
Hybrid nanoparticles have emerged as promising tools in cancer diagnosis and treatment, offering the potential for early detection and precise eradication of malignant cells by integrating diverse materials. However, navigating the intricacies, limitations, and hurdles within this domain underscores the importance of thoughtful decision-making. This editorial provides a comprehensive exploration of the merits and challenges of nanotechnology in the context of cancer diagnosis, therapy, and theranostics. It sheds light on the current applications and delves into the promising future prospects in this field. By doing so, this editorial aims to foster a deeper understanding of the intricacies involved in designing efficient protocols for hybrid nanoparticle production, contributing to advancing cancer management strategies.
1- Ali Tarighatnia, Gurkaran Johal, Ayuob Aghanejad, Hossein Ghadiri, and Nader D Nader, "Tips and tricks in molecular imaging: a practical approach." Frontiers in Biomedical Technologies, Vol. 8 (No. 3), pp. 226-35, (2021).
2- Ali Tarighatnia, Mohammad Reza Fouladi, Nader D Nader, Ayuob Aghanejad, and Hossein Ghadiri, "Recent trends of contrast agents in ultrasound imaging: a review of the classifications and applications." Materials advances, Vol. 3 (No. 9), pp. 3726-41, (2022).
3- Ali Tarighatnia et al., "Mucin-16 targeted mesoporous nano-system for evaluation of cervical cancer via dual-modal computed tomography and ultrasonography." New journal of chemistry, Vol. 45 (No. 40), pp. 18871-80, (2021).
4- Javed Ahmad, Anuj Garg, Gulam Mustafa, Mohammad Zaki Ahmad, Mohammed Aslam, and Awanish Mishra, "Hybrid Quantum Dot as Promising Tools for Theranostic Application in Cancer." Electronics, Vol. 12 (No. 4), p. 972, (2023).
5- Nasim Vahidfar, Ayuob Aghanejad, Hojjat Ahmadzadehfar, Saeed Farzanehfar, and Elisabeth Eppard, "Theranostic advances in breast cancer in nuclear medicine." International Journal of Molecular Sciences, Vol. 22 (No. 9), p. 4597, (2021).
6- Behrouz Foroughi-Nia, Jaleh Barar, Mohammad Yousef Memar, Ayuob Aghanejad, and Soudabeh Davaran, "Progresses in polymeric nanoparticles for delivery of tyrosine kinase inhibitors." Life sciences, Vol. 278p. 119642, (2021).
7- Ayeskanta Mohanty, Saji Uthaman, and In-Kyu Park, "Utilization of polymer-lipid hybrid nanoparticles for targeted anti-cancer therapy." Molecules, Vol. 25 (No. 19), p. 4377, (2020).
8- Ali Tarighatnia, Behrouz Foroughi-Nia, Nader D. Nader, and Ayuob Aghanejad, "Recent trends and advances in nanosystems with tyrosine kinase inhibitors for image-guided cancer treatments." Journal of Drug Delivery Science and Technology, Vol. 88p. 104938, 2023/10/01/ (2023).
9- Yurena Luengo Morato, Marzia Marciello, Laura Lozano Chamizo, Karina Ovejero Paredes, and Marco Filice, "Hybrid magnetic nanoparticles for multimodal molecular imaging of cancer." in Magnetic Nanoparticle-Based Hybrid Materials: Elsevier, (2021), pp. 343-86.
10- Seulki Lee and Xiaoyuan Chen, "Dual-modality probes for in vivo molecular imaging." Molecular imaging, Vol. 8 (No. 2), p. 7290.2009. 00013, (2009).
11- Azadeh Amraee et al., "Ultrasmall iron oxide nanoparticles and gadolinium-based contrast agents in magnetic resonance imaging: a systematic review and meta-analysis." Clinical and Translational Imaging, Vol. 11 (No. 1), pp. 83-93, (2023).
12- Zahra Bakhtiary, Amir Ata Saei, Mohammad J Hajipour, Mohammad Raoufi, Ophir Vermesh, and Morteza Mahmoudi, "Targeted superparamagnetic iron oxide nanoparticles for early detection of cancer: Possibilities and challenges." Nanomedicine: Nanotechnology, Biology and Medicine, Vol. 12 (No. 2), pp. 287-307, (2016).
13- Paniz Siminzar, Mohammad Reza Tohidkia, Elisabeth Eppard, Nasim Vahidfar, Ali Tarighatnia, and Ayuob Aghanejad, "Recent trends in diagnostic biomarkers of tumor microenvironment." Molecular Imaging and Biology, Vol. 25 (No. 3), pp. 464-82, (2023).
14- Carolina Salvador Morales, Pedro M Valencia, Anjali B Thakkar, Edward Swanson, and Robert Langer, "Recent developments in multifunctional hybrid nanoparticles: opportunities and challenges in cancer therapy." Frontiers in Bioscience-Elite, Vol. 4 (No. 1), pp. 529-45, (2012).
15- Ali Tarighatnia et al., "Engineering and quantification of bismuth nanoparticles as targeted contrast agent for computed tomography imaging in cellular and animal models." Journal of drug delivery science and technology, Vol. 66p. 102895, (2021).
16- María Gabriela Montiel Schneider et al., "Biomedical applications of iron oxide nanoparticles: Current insights progress and perspectives." Pharmaceutics, Vol. 14 (No. 1), p. 204, (2022).
17- Nasim Jamshidi, Ali Tarighatnia, Mona Fazel Ghaziyani, Fakhrossadat Sajadian, and Nader D Nader, "Folic acid-conjugated Fe-Au-based nanoparticles for dual detection of breast cancer cells by magnetic resonance imaging and computed tomography." Frontiers in Biomedical Technologies, (2023).
18- Jamileh Kadkhoda, Ali Tarighatnia, Mohammad Reza Tohidkia, Nader D Nader, and Ayuob Aghanejad, "Photothermal therapy-mediated autophagy in breast cancer treatment: Progress and trends." Life Sciences, Vol. 298p. 120499, (2022).
19- Jamileh Kadkhoda, Ali Tarighatnia, Jaleh Barar, Ayuob Aghanejad, and Soodabeh Davaran, "Recent advances and trends in nanoparticles based photothermal and photodynamic therapy." Photodiagnosis and photodynamic therapy, Vol. 37p. 102697, (2022).
20- Jamileh Kadkhoda, Ali Tarighatnia, Nader D Nader, and Ayuob Aghanejad, "Targeting mitochondria in cancer therapy: Insight into photodynamic and photothermal therapies." Life Sciences, p. 120898, (2022).
21- Keyvan Kheyrolahzadeh, Mohammad Reza Tohidkia, Ali Tarighatnia, Parviz Shahabi, Nader D Nader, and Ayuob Aghanejad, "Theranostic chimeric antigen receptor (CAR)-T cells: Insight into recent trends and challenges in solid tumors." Life Sciences, p. 121917, (2023).
22- Ayuob Aghanejad et al., "A review on targeting tumor microenvironment: The main paradigm shift in the mAb-based immunotherapy of solid tumors." International Journal of Biological Macromolecules, Vol. 207pp. 592-610, (2022).
23- Seraj Mohaghegh, Ali Tarighatnia, Yadollah Omidi, Jaleh Barar, Ayuob Aghanejad, and Khosro Adibkia, "Multifunctional magnetic nanoparticles for MRI-guided co-delivery of erlotinib and L-asparaginase to ovarian cancer." Journal of Microencapsulation, Vol. 39 (No. 4), pp. 394-408, (2022).
2- Ali Tarighatnia, Mohammad Reza Fouladi, Nader D Nader, Ayuob Aghanejad, and Hossein Ghadiri, "Recent trends of contrast agents in ultrasound imaging: a review of the classifications and applications." Materials advances, Vol. 3 (No. 9), pp. 3726-41, (2022).
3- Ali Tarighatnia et al., "Mucin-16 targeted mesoporous nano-system for evaluation of cervical cancer via dual-modal computed tomography and ultrasonography." New journal of chemistry, Vol. 45 (No. 40), pp. 18871-80, (2021).
4- Javed Ahmad, Anuj Garg, Gulam Mustafa, Mohammad Zaki Ahmad, Mohammed Aslam, and Awanish Mishra, "Hybrid Quantum Dot as Promising Tools for Theranostic Application in Cancer." Electronics, Vol. 12 (No. 4), p. 972, (2023).
5- Nasim Vahidfar, Ayuob Aghanejad, Hojjat Ahmadzadehfar, Saeed Farzanehfar, and Elisabeth Eppard, "Theranostic advances in breast cancer in nuclear medicine." International Journal of Molecular Sciences, Vol. 22 (No. 9), p. 4597, (2021).
6- Behrouz Foroughi-Nia, Jaleh Barar, Mohammad Yousef Memar, Ayuob Aghanejad, and Soudabeh Davaran, "Progresses in polymeric nanoparticles for delivery of tyrosine kinase inhibitors." Life sciences, Vol. 278p. 119642, (2021).
7- Ayeskanta Mohanty, Saji Uthaman, and In-Kyu Park, "Utilization of polymer-lipid hybrid nanoparticles for targeted anti-cancer therapy." Molecules, Vol. 25 (No. 19), p. 4377, (2020).
8- Ali Tarighatnia, Behrouz Foroughi-Nia, Nader D. Nader, and Ayuob Aghanejad, "Recent trends and advances in nanosystems with tyrosine kinase inhibitors for image-guided cancer treatments." Journal of Drug Delivery Science and Technology, Vol. 88p. 104938, 2023/10/01/ (2023).
9- Yurena Luengo Morato, Marzia Marciello, Laura Lozano Chamizo, Karina Ovejero Paredes, and Marco Filice, "Hybrid magnetic nanoparticles for multimodal molecular imaging of cancer." in Magnetic Nanoparticle-Based Hybrid Materials: Elsevier, (2021), pp. 343-86.
10- Seulki Lee and Xiaoyuan Chen, "Dual-modality probes for in vivo molecular imaging." Molecular imaging, Vol. 8 (No. 2), p. 7290.2009. 00013, (2009).
11- Azadeh Amraee et al., "Ultrasmall iron oxide nanoparticles and gadolinium-based contrast agents in magnetic resonance imaging: a systematic review and meta-analysis." Clinical and Translational Imaging, Vol. 11 (No. 1), pp. 83-93, (2023).
12- Zahra Bakhtiary, Amir Ata Saei, Mohammad J Hajipour, Mohammad Raoufi, Ophir Vermesh, and Morteza Mahmoudi, "Targeted superparamagnetic iron oxide nanoparticles for early detection of cancer: Possibilities and challenges." Nanomedicine: Nanotechnology, Biology and Medicine, Vol. 12 (No. 2), pp. 287-307, (2016).
13- Paniz Siminzar, Mohammad Reza Tohidkia, Elisabeth Eppard, Nasim Vahidfar, Ali Tarighatnia, and Ayuob Aghanejad, "Recent trends in diagnostic biomarkers of tumor microenvironment." Molecular Imaging and Biology, Vol. 25 (No. 3), pp. 464-82, (2023).
14- Carolina Salvador Morales, Pedro M Valencia, Anjali B Thakkar, Edward Swanson, and Robert Langer, "Recent developments in multifunctional hybrid nanoparticles: opportunities and challenges in cancer therapy." Frontiers in Bioscience-Elite, Vol. 4 (No. 1), pp. 529-45, (2012).
15- Ali Tarighatnia et al., "Engineering and quantification of bismuth nanoparticles as targeted contrast agent for computed tomography imaging in cellular and animal models." Journal of drug delivery science and technology, Vol. 66p. 102895, (2021).
16- María Gabriela Montiel Schneider et al., "Biomedical applications of iron oxide nanoparticles: Current insights progress and perspectives." Pharmaceutics, Vol. 14 (No. 1), p. 204, (2022).
17- Nasim Jamshidi, Ali Tarighatnia, Mona Fazel Ghaziyani, Fakhrossadat Sajadian, and Nader D Nader, "Folic acid-conjugated Fe-Au-based nanoparticles for dual detection of breast cancer cells by magnetic resonance imaging and computed tomography." Frontiers in Biomedical Technologies, (2023).
18- Jamileh Kadkhoda, Ali Tarighatnia, Mohammad Reza Tohidkia, Nader D Nader, and Ayuob Aghanejad, "Photothermal therapy-mediated autophagy in breast cancer treatment: Progress and trends." Life Sciences, Vol. 298p. 120499, (2022).
19- Jamileh Kadkhoda, Ali Tarighatnia, Jaleh Barar, Ayuob Aghanejad, and Soodabeh Davaran, "Recent advances and trends in nanoparticles based photothermal and photodynamic therapy." Photodiagnosis and photodynamic therapy, Vol. 37p. 102697, (2022).
20- Jamileh Kadkhoda, Ali Tarighatnia, Nader D Nader, and Ayuob Aghanejad, "Targeting mitochondria in cancer therapy: Insight into photodynamic and photothermal therapies." Life Sciences, p. 120898, (2022).
21- Keyvan Kheyrolahzadeh, Mohammad Reza Tohidkia, Ali Tarighatnia, Parviz Shahabi, Nader D Nader, and Ayuob Aghanejad, "Theranostic chimeric antigen receptor (CAR)-T cells: Insight into recent trends and challenges in solid tumors." Life Sciences, p. 121917, (2023).
22- Ayuob Aghanejad et al., "A review on targeting tumor microenvironment: The main paradigm shift in the mAb-based immunotherapy of solid tumors." International Journal of Biological Macromolecules, Vol. 207pp. 592-610, (2022).
23- Seraj Mohaghegh, Ali Tarighatnia, Yadollah Omidi, Jaleh Barar, Ayuob Aghanejad, and Khosro Adibkia, "Multifunctional magnetic nanoparticles for MRI-guided co-delivery of erlotinib and L-asparaginase to ovarian cancer." Journal of Microencapsulation, Vol. 39 (No. 4), pp. 394-408, (2022).
| Files | ||
| Issue | Vol 11 No 1 (2024) | |
| Section | Editorial | |
| DOI | https://doi.org/10.18502/fbt.v11i1.14503 | |
| Keywords | ||
| Hybrid Nanoparticles Contrast Agents Cancer Diagnosis Cancer Treatment | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
How to Cite
1.
Tarighatnia A, Mahmoudi G, Kiani M, Nader N. Current Challenges and New Opportunities of Hybrid Nanoparticles for Diagnosis and Treatment of Cancer. Frontiers Biomed Technol. 2024;11(1):1-5.
